
Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- U.S. healthcare: consumer responses to viewing advertisements for medicines
- Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Small molecules facing loss of developed market exclusivity 2011-2020
- New medicine availability by therapy area in the U.S. 2013
- Medicinal market growth by world region, specialty and traditional 2013-2018
- Medicinal market growth worldwide including rebates 2009-2018
- Medicine doses consumed globally by region 2015 and 2020 forecast
- Median duration of drug shortages in Canada 2013-2016
- Biologics share of global pharmaceutical spending 2002-2017
- U.S. insured patients' out-of-pocket health spending 2008-2011
- Market distribution of human insulin in hospitals in China 2018
- Total biopharmaceutical revenue worldwide 2006-2011
- Net financial results in the pharmaceuticals industry in Poland 2015-2019
- Pharmaceutical products production in Poland 2005-2020
- Changes in prescriptions for U.S. young adults
- Medicines and medical materials investment in Russia 2015-2021
- Number of Canadian laboratory medicine specialists 2019, by area
- Value of pharmaceuticals distributed in public hospitals Thailand 2020, by type
PhRMA. (December 15, 2020). Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category* [Graph]. In Statista. Retrieved May 19, 2022, from https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. "Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*." Chart. December 15, 2020. Statista. Accessed May 19, 2022. https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. (2020). Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*. Statista. Statista Inc.. Accessed: May 19, 2022. https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. "Number of Biopharma Medicines in Development in The U.S. as of April 2020, by Select Therapeutic Category*." Statista, Statista Inc., 15 Dec 2020, https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA, Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category* Statista, https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/ (last visited May 19, 2022)